Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quest Diagnostics
(NY:
DGX
)
138.96
+0.76 (+0.55%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
911,183
Open
138.64
Bid (Size)
135.85 (1)
Ask (Size)
146.99 (1)
Prev. Close
138.20
Today's Range
137.90 - 139.69
52wk Range
119.59 - 145.62
Shares Outstanding
122,180,759
Dividend Yield
2.04%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Myriad Genetics Sees Stock Surge with Hereditary Cancer Tests
June 18, 2024
Myriad Genetics Inc. (NASDAQ: MYGN) is a leader in genetic testing and precision medicine. The company offers a wide variety of genetic tests including
Via
MarketBeat
Peering Into Quest Diagnostics's Recent Short Interest
June 10, 2024
Via
Benzinga
Performance
YTD
-1.32%
-1.32%
1 Month
-0.77%
-0.77%
3 Month
+7.49%
+7.49%
6 Month
+1.61%
+1.61%
1 Year
-1.79%
-1.79%
More News
Read More
Analyst Scoreboard: 7 Ratings For Quest Diagnostics
May 30, 2024
Via
Benzinga
How Is The Market Feeling About Quest Diagnostics?
May 24, 2024
Via
Benzinga
Employers Struggle with Drug Test Policies Amid Varying State Laws, Cheating on Drug Tests Reaches 30-Year High
May 15, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
April 29, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Peering Into Quest Diagnostics's Recent Short Interest
April 24, 2024
Via
Benzinga
The Analyst Landscape: 5 Takes On Quest Diagnostics
April 24, 2024
Via
Benzinga
Balancing Dividends and Fundamentals: The Case of NYSE:DGX.
April 10, 2024
Via
Chartmill
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
April 30, 2024
Via
AB Newswire
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth
April 25, 2024
Via
Talk Markets
Quest Diagnostics Says Sales In Q1 Increased For The First Time Since The Height Of Pandemic
April 23, 2024
Via
Benzinga
DGX Stock Earnings: Quest Diagnostics Beats EPS, Beats Revenue for Q1 2024
April 23, 2024
Via
InvestorPlace
US Stocks Set To Open Fresh Week Higher On Big Tech Earnings Hopes: Analyst Warns Any Letdown Could Push Market 'Deeper Into Oversold Territory'
April 22, 2024
Via
Benzinga
Key Takeaways From Quest Diagnostics Analyst Ratings
March 20, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
March 19, 2024
Via
Chartmill
Earnings Scheduled For April 23, 2024
April 23, 2024
Via
Benzinga
(DGX) - Analyzing Quest Diagnostics's Short Interest
March 05, 2024
Via
Benzinga
Why NYSE:DGX provides a good dividend, while having solid fundamentals.
February 27, 2024
Via
Chartmill
Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
April 21, 2024
Via
Benzinga
LifeMD Shares Come Back to Life on GLP-1 Business Growth
March 19, 2024
Via
MarketBeat
AMC Entertainment Tops The List Of High-Yielding Corporate Bonds — A Look At Yields As Bond Appetites Grow
March 18, 2024
Via
Benzinga
Topics
Bonds
Exposures
Debt Markets
Breaking Down Quest Diagnostics: 7 Analysts Share Their Views
February 26, 2024
Via
Benzinga
Spotify To Rally Around 36%? Here Are 10 Top Analyst Forecasts For Wednesday
February 07, 2024
Via
Benzinga
Is NYSE:DGX suited for dividend investing?
February 05, 2024
Via
Chartmill
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.